Brimonidine-Soluplus Nanomicelles: Preparation and in-vitro evaluation
Brimonidine is an active pharmaceutical ingredient used to treat glaucoma as a topical eye drop. Ophthalmic topical preparations are associated with low ocular bioavailability due to several physiological and analytical barriers. Many approaches have been investigated to overcome this problem, for...
Saved in:
| Main Authors: | Noor Al wiswasi, Fatima J. Al-Gawahri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy University of Baghdad
2025-03-01
|
| Series: | Iraqi Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olmesartan Medoxomil Nanomicelle Using Soluplus for Dissolution Enhancement :Preparation, In-vitro and Ex-vivo Evaluation
by: Nawal Ayash Rajab, et al.
Published: (2025-06-01) -
Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma
by: Shazma Gohar, et al.
Published: (2024-11-01) -
Fabrication of Anti-glaucoma Nanofibers as Controlled-Release Inserts for Ophthalmic Delivery of Brimonidine Tartrate: In Vivo Evaluation in Caprine Eye
by: Fariba Shaikhi Shoushtari, et al.
Published: (2024-07-01) -
Novel Uses of Brimonidine
by: Hikkalagutti. S. Kruthika, et al.
Published: (2024-07-01) -
A Multicenter Randomized Double-Masked Study Comparing Preservative-free Brimonidine Tartrate Ophthalmic Solution 0.025% with LUMIFY® 0.025% for Ocular Redness in Adults
by: Melissa Toyos, et al.
Published: (2025-07-01)